Benchmark analyst Bruce Jackson reiterated a Buy rating and $3.00 price target on Biofrontera (NASDAQ: BFRI).The analyst commented, "We are ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE